A good place to start Trump’s new health care plan: More drugs over the counter

February 13, 2026 - 03:48

A push to increase the availability of safe prescription medications over the counter is gaining traction as a potential cornerstone for healthcare reform. The proposal specifically highlights making albuterol, a crucial asthma inhaler medication, available without a prescription as a logical starting point.

Proponents argue this shift would deliver a dual benefit for American consumers: significantly lowering costs and dramatically improving access. Removing the prescription barrier eliminates the expense and time required for doctor visits, allowing patients to manage common, well-understood conditions more directly and affordably. For millions managing asthma, easy access to albuterol could prevent minor breathing difficulties from escalating into costly emergency room visits.

The initiative calls upon the Food and Drug Administration to rigorously review and reclassify a broader range of medications that are deemed safe and effective for self-care. The focus would be on drugs with long-established safety profiles and clear usage instructions that consumers can follow independently. This approach aims to empower patients, reduce bureaucratic hurdles, and alleviate financial burdens within the healthcare system, framing self-reliance and market competition as pathways to more accessible everyday medicine.